(Q34202383)

31 July 2017

1 reference

title

Oral candidosis--clinical challenges of a biofilm disease (English)

1 reference

31 July 2017

0 references

Riina Rautemaa

1

1 reference

31 July 2017

Gordon Ramage

series ordinal

2

1 reference

31 July 2017

language of work or name

English

0 references

publication date

21 July 2011

1 reference

Critical Reviews in Microbiology

31 July 2017

published in

1 reference

31 July 2017

volume

37

1 reference

31 July 2017

issue

4

1 reference

31 July 2017

page(s)

328-336

1 reference

Oral lichen planus and oral lichenoid lesions: diagnostic and therapeutic considerations

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F1040841X.2011.585606

Antifungal combinations against Candida albicans biofilms in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1040841X.2011.585606

In vitro activity of caspofungin against Candida albicans biofilms.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1040841X.2011.585606

Susceptibility to Melaleuca alternifolia (tea tree) oil of yeasts isolated from the mouths of patients with advanced cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1040841X.2011.585606

Comparison of the efficacy and safety of miconazole 50-mg mucoadhesive buccal tablets with miconazole 500-mg gel in the treatment of oropharyngeal candidiasis: a prospective, randomized, single-blind, multicenter, comparative, phase III trial in pat

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1040841X.2011.585606

Antifungal resistance of candidal biofilms formed on denture acrylic in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1040841X.2011.585606

Mixed Candida albicans and Candida glabrata populations associated with the pathogenesis of denture stomatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1040841X.2011.585606

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1040841X.2011.585606

Bacterial biofilms: a common cause of persistent infections

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1040841X.2011.585606

Esophageal cancer associated with chronic mucocutaneous candidiasis. Could chronic candidiasis lead to esophageal cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1040841X.2011.585606

Biofilms: survival mechanisms of clinically relevant microorganisms

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1040841X.2011.585606

Adjunctive use of chlorhexidine in oral candidoses: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1040841X.2011.585606

EUCAST definitive document EDef 7.1: method for the determination of broth dilution MICs of antifungal agents for fermentative yeasts

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1040841X.2011.585606

Characterization of the oral fungal microbiome (mycobiome) in healthy individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1040841X.2011.585606

Antifungal effects of Melaleuca alternifolia (tea tree) oil and its components on Candida albicans, Candida glabrata and Saccharomyces cerevisiae

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1040841X.2011.585606

Oral microbial communities in sickness and in health.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1040841X.2011.585606

Reducing the incidence of denture stomatitis: are denture cleansers sufficient?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1040841X.2011.585606

Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1040841X.2011.585606

Xylitol and its vehicles for public health needs

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1040841X.2011.585606

Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1040841X.2011.585606

Candida albicans secreted aspartyl proteinases in virulence and pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1040841X.2011.585606

Quantitative expression of the Candida albicans secreted aspartyl proteinase gene family in human oral and vaginal candidiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1040841X.2011.585606

Hydrolytic enzyme production is associated with Candida albicans biofilm formation from patients with type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1040841X.2011.585606

Candida biofilms on implanted biomaterials: a clinically significant problem

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1040841X.2011.585606

Our current understanding of fungal biofilms

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1040841X.2011.585606

Inhibition of Candida albicans biofilm formation by farnesol, a quorum-sensing molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1040841X.2011.585606

Denture stomatitis: a role for Candida biofilms

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1040841X.2011.585606

Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1040841X.2011.585606

In vitro pharmacodynamic properties of three antifungal agents against preformed Candida albicans biofilms determined by time-kill studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1040841X.2011.585606

Inhibition on Candida albicans biofilm formation using divalent cation chelators (EDTA).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1040841X.2011.585606

Quorum sensing inhibitors: a bargain of effects

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1040841X.2011.585606

Decreased susceptibility of Candida albicans to azole antifungals: a complication of long-term treatment in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1040841X.2011.585606

Reduction of fluconazole susceptibility of Candida albicans in APECED patients due to long-term use of ketoconazole and miconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1040841X.2011.585606

Acetaldehyde: a cumulative carcinogen in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1040841X.2011.585606

Lactobacillus bacteremia, clinical significance, and patient outcome, with special focus on probiotic L. rhamnosus GG

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1040841X.2011.585606

Oral mucosal fungal infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1040841X.2011.585606

Persistent Candida albicans colonization and molecular mechanisms of azole resistance in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1040841X.2011.585606

Antifungal activity of black tea polyphenols (catechins and theaflavins) against Candida species

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1040841X.2011.585606

Changing trends in the epidemiology of Candida blood stream infections: a matter for concern?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1040841X.2011.585606

Antimicrobials as a contributory factor in oral candidosis--a brief overview.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1040841X.2011.585606

Antibiotic resistance of bacteria in biofilms

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1040841X.2011.585606

Oropharyngeal candidiasis in the era of antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1040841X.2011.585606

The European Confederation of Medical Mycology (ECMM) survey of candidaemia in Italy: in vitro susceptibility of 375 Candida albicans isolates and biofilm production

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1040841X.2011.585606

Chronic candidosis and oral cancer in APECED-patients: production of carcinogenic acetaldehyde from glucose and ethanol by Candida albicans

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1040841X.2011.585606

Interaction of Candida albicans biofilms with antifungals: transcriptional response and binding of antifungals to beta-glucans

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1040841X.2011.585606

10.3109/1040841X.2011.585606

21 January 2018

Identifiers

DOI

1 reference

31 July 2017

1 reference